Baseline Characteristics in Patients with Atopic Dermatitis from the North American Prospective Observational Study of Lebrikizumab (ADjoy). (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s734. https://doi.org/10.25251/djee0862